Corient Private Wealth Portfolio holdings
Corient Private Wealth is the U.S. wealth management business that grew out of Canadian asset manager CI Financial's push into American wealth advisers. It was called CI Private Wealth until 2023, when it took the name Corient, a play on the words "client" and "oriented." Its advisers typically manage client portfolios by hiring and replacing outside investment managers and choosing individual securities, guided by an investment committee. Clients include individuals, among them high-net-worth individuals, as well as trusts, estates and charitable organizations.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$313M |
| 2 |
RTX Corp
RTX
|
+$247M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$246M |
| 4 |
Quanta Services
PWR
|
+$126M |
| 5 |
Marvell Technology
MRVL
|
+$94.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab International Equity ETF
SCHF
|
+$449M |
| 2 |
NVIDIA
NVDA
|
+$392M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$375M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$331M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$330M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.68% |
| 2 | Technology | 19.67% |
| 3 | Financials | 9.21% |
| 4 | Industrials | 7.58% |
| 5 | Healthcare | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1201
Associated Banc-Corp
ASB
$5.63B
| $2.68M | ﹤0.01% |
87,085
-13,427
| -13% | -$378K |
2022 Q4
14 quarters
|
|
1202
Estee Lauder
EL
$39.6B
| $2.67M | ﹤0.01% |
33,863
-6,567
| -16% | -$530K |
2022 Q4
14 quarters
|
|
1203
LivaNova
LIVN
$4.35B
| $2.67M | ﹤0.01% |
32,454
-2,058
| -6% | -$146K |
2025 Q4
2 quarters
|
|
1204
ADMA Biologics
ADMA
$2.56B
| $2.66M | ﹤0.01% |
317,861
+254,124
| +399% | +$2.32M |
2022 Q4
14 quarters
|
|
1205
FMC
FMC
$964M
| $2.66M | ﹤0.01% |
231,233
-86,921
| -27% | -$1.21M |
2022 Q4
14 quarters
|
|
1206
iShares MSCI United Kingdom ETF
EWU
$3.74B
| $2.66M | ﹤0.01% |
57,562
-2,198
| -4% | -$103K |
2022 Q4
14 quarters
|
|
1207
Versant Media Group
VSNT
$4.37B
| $2.65M | ﹤0.01% |
73,690
-41,994
| -36% | -$1.69M |
2026 Q1
1 quarter
|
|
1208
FIVE9
FIVN
$2.72B
| $2.65M | ﹤0.01% |
+124,436
| New | +$2.46M |
2026 Q2
0 quarters
|
|
1209
Webull Corp
BULL
$2.79B
| $2.65M | ﹤0.01% |
406,761
+176,233
| +76% | +$1.14M |
2026 Q1
1 quarter
|
|
1210
DELISTED
TopBuild
BLD
| $2.65M | ﹤0.01% |
7,478
-249
| -3% | -$103K |
2023 Q2
12 quarters
|
|
1211
WaFd
WAFD
$2.17B
| $2.64M | ﹤0.01% |
68,899
+14,326
| +26% | +$505K |
2022 Q4
14 quarters
|
|
1212
Texas Capital Bancshares
TCBI
$4.42B
| $2.64M | ﹤0.01% |
25,566
+5,937
| +30% | +$596K |
2025 Q4
2 quarters
|
|
1213
Brink's
BCO
$4.23B
| $2.64M | ﹤0.01% |
27,923
-19,142
| -41% | -$1.99M |
2026 Q1
1 quarter
|
|
1214
CNA Financial
CNA
$13.2B
| $2.63M | ﹤0.01% |
54,203
-37,699
| -41% | -$1.72M |
2025 Q3
3 quarters
|
|
1215
Thor Industries
THO
$3.81B
| $2.63M | ﹤0.01% |
34,935
+8,572
| +33% | +$660K |
2023 Q1
13 quarters
|
|
1216
First Advantage
FA
$3.71B
| $2.62M | ﹤0.01% |
145,206
+39,297
| +37% | +$569K |
2026 Q1
1 quarter
|
|
1217
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.18B
| $2.62M | ﹤0.01% |
2,265
+1,442
| +175% | +$1.7M |
2023 Q1
13 quarters
|
|
1218
Dimensional Emerging Markets Sustainability Core 1 ETF
DFSE
$590M
| $2.62M | ﹤0.01% |
53,535
-857
| -2% | -$41K |
2023 Q4
10 quarters
|
|
1219
Henry Schein
HSIC
$9.46B
| $2.61M | ﹤0.01% |
31,308
+1,463
| +5% | +$112K |
2022 Q4
14 quarters
|
|
1220
Hayward Holdings
HAYW
$3.36B
| $2.61M | ﹤0.01% |
151,001
+63,806
| +73% | +$932K |
2024 Q3
7 quarters
|
|
1221
Cooper Companies
COO
$11.3B
| $2.61M | ﹤0.01% |
36,394
+13,127
| +56% | +$858K |
2022 Q4
14 quarters
|
|
1222
Amneal Pharmaceuticals
AMRX
$7.49B
| $2.61M | ﹤0.01% |
150,698
+139,568
| +1,254% | +$1.91M |
2025 Q4
2 quarters
|
|
1223
POSCO
PKX
$15B
| $2.61M | ﹤0.01% |
50,761
+10,699
| +27% | +$733K |
2022 Q4
14 quarters
|
|
1224
Omnicell
OMCL
$1.67B
| $2.61M | ﹤0.01% |
62,809
+20,000
| +47% | +$806K |
2026 Q1
1 quarter
|
|
1225
Regenxbio
RGNX
$475M
| $2.61M | ﹤0.01% |
+217,661
| New | +$1.81M |
2026 Q2
0 quarters
|
|
Similar funds
Corient Private Wealth's Q2 2026 Portfolio in Review
As of Q2 2026, Corient Private Wealth held 3,273 positions worth $72.2B, up 3.4% from $69.9B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Corient Private Wealth withdrew a net $6.91B in Q2 2026, closing 231 positions and reducing 1,294 holdings. Its most notable exit was Masimo, an estimated $57.2M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, down from 37% a quarter earlier, followed by Technology and Financials.
Against the trend, Corient Private Wealth opened a new position in Powerlaw Corp worth $56.7M.
- Corient Private Wealth's largest Q2 2026 buy was Powerlaw Corp: 3,862,217 shares worth $56.7M.
- Corient Private Wealth added most to Invesco QQQ Trust in Q2 2026, an estimated $313M increase.
- Corient Private Wealth's biggest Q2 2026 reduction was Schwab International Equity ETF, cutting an estimated $449M.
- Corient Private Wealth fully exited Masimo in Q2 2026, selling an estimated $57.2M.
- Corient Private Wealth's ten largest holdings make up 27% of its $72.2B portfolio in Q2 2026.
- Corient Private Wealth opened 439 new positions and closed 231 in Q2 2026.
- Corient Private Wealth's portfolio value rose 3.4% quarter-over-quarter to $72.2B.
Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.